ML&P Blog: Our insight into current issues

Medicines Law & Policy periodically will post timely analysis and insight into current events related to intellectual property and innovation policy as they impact on access to medicines. These posts are listed below. We also have a newsletter for those interested in being notified when new articles are posted.

Latest Blog Posts

Wrapping up 2024: Noteworthy events in medicines law and policy around the globe

Welcome to Medicines Law & Policy’s  end of the year blog, our highly biased annual overview of memorable medicines law and policy events. January At the...

Ensure greater transparency and meaningful participation for a better pandemic accord

This statement was delivered by Medicines Law & Policy at the Intergovernmental Negotiating Body (INB), Session 12 (resumed), 6 December 2024 Madam co-chair (s), members...

Pandemic treaty must ensure timely access to technology and know-how

This statement was delivered by Medicines Law & Policy at the Intergovernmental Negotiating Body (INB), Session 12 (resumed), 4 December 2024 Thank you, co-chairs. We...

Transfer of Technology: New definition and stronger language needed

Statement by Medicines Law & Policy on Article 11, Technology Transfer Intergovernmental Negotiating Body on a Pandemic Accord (INB), Session 12 Delivered at the WHO on...

Getting to a meaningful agreement: ML&P’s opening statement to the 12th round of pandemic accord negotiations

Thank you for giving us the opportunity to address the opening session of the INB12. We would like to make the following points: A pandemic agreement...

UN “Pact for the Future” intellectual property actions need revision to ensure innovation and access to health products for all

UPDATE: From 22-23 September 2024, the Summit of the Future took place and adopted the Pact for the Future. The intellectual property paragraph of...

World Trade Organization Members Embark on Review of the TRIPS Agreement

The World Trade Organization (WTO) Trade-Related Aspects of Intellectual Property Rights (TRIPS) Council will meet on 10-11 July. On the agenda is the review...

MSF’s Access Campaign is an invaluable actor in global health; shutting it down is short-sighted.

On 20 June, STAT News reported that Médecins Sans Frontières (MSF) is closing down their Access Campaign, effective as of 31 December 2024. It...

The new IP strategy of war-torn Ukraine should prioritise public health and national security

Russia’s full-scale assault on Ukraine continues for the third year. The Russian occupation forces have already killed tens of thousands of civilians, including children. They have...

Continuing to ignore the problem of the know-how gap won’t make it go away.

The Covid-19 pandemic was a wake-up call for a variety of issues in access to medicines, one of which was finding a solution to...

Newsletter

Never miss a post! Sign up for ML&P's newsletter.

Posts by topic

Year-End Wrap-Ups